VVOS [NASD]
Vivos Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.96 Insider Own21.63% Shs Outstand23.03M Perf Week-5.23%
Market Cap33.60M Forward P/E- EPS next Y-0.70 Insider Trans0.00% Shs Float18.04M Perf Month-16.67%
Income-20.30M PEG- EPS next Q-0.26 Inst Own10.30% Short Float1.51% Perf Quarter-50.51%
Sales16.90M P/S1.99 EPS this Y-44.30% Inst Trans10.67% Short Ratio2.98 Perf Half Y-45.49%
Book/sh1.11 P/B1.31 EPS next Y25.80% ROA-53.60% Target Price4.50 Perf Year-72.38%
Cash/sh1.04 P/C1.40 EPS next 5Y- ROE-70.40% 52W Range1.18 - 7.09 Perf YTD-35.56%
Dividend- P/FCF- EPS past 5Y- ROI-75.20% 52W High-79.83% Beta-
Dividend %- Quick Ratio3.60 Sales past 5Y- Gross Margin74.60% 52W Low21.19% ATR0.21
Employees158 Current Ratio3.60 Sales Q/Q33.30% Oper. Margin- RSI (14)40.57 Volatility12.68% 15.49%
OptionableYes Debt/Eq0.06 EPS Q/Q-2.00% Profit Margin- Rel Volume0.05 Prev Close1.45
ShortableYes LT Debt/Eq0.01 EarningsMay 16 AMC Payout- Avg Volume91.49K Price1.43
Recom2.00 SMA20-12.22% SMA50-27.58% SMA200-52.20% Volume3,664 Change-1.38%
May-21-22 08:35AM  
May-16-22 04:05PM  
Apr-28-22 07:30AM  
Apr-26-22 08:26AM  
Mar-31-22 04:05PM  
08:14AM  
Mar-08-22 09:11AM  
Mar-03-22 08:00AM  
Mar-02-22 08:00AM  
Feb-24-22 08:00AM  
Jan-27-22 07:30AM  
Jan-19-22 01:27PM  
11:44AM  
07:30AM  
Dec-14-21 01:11PM  
07:30AM  
Dec-09-21 07:30AM  
Dec-03-21 07:30AM  
Nov-15-21 04:05PM  
07:00AM  
Nov-09-21 07:30AM  
Oct-22-21 07:30AM  
Oct-20-21 11:17AM  
Oct-19-21 04:00PM  
11:30AM  
Oct-18-21 07:30AM  
Oct-13-21 10:59AM  
07:30AM  
Sep-29-21 07:03AM  
Sep-23-21 12:28PM  
07:30AM  
Sep-22-21 11:01AM  
07:30AM  
Sep-08-21 07:30AM  
Aug-26-21 09:08AM  
07:30AM  
Aug-24-21 10:13AM  
Aug-23-21 02:44PM  
11:17AM  
09:27AM  
08:36AM  
07:57AM  
07:30AM  
07:15AM  
Aug-17-21 04:05PM  
Aug-12-21 04:05PM  
Aug-09-21 04:05PM  
08:00AM  
Jul-29-21 08:00AM  
Jul-13-21 08:00AM  
Jul-07-21 08:00AM  
Jun-15-21 06:41AM  
May-26-21 08:00AM  
May-17-21 04:05PM  
03:15PM  
May-14-21 07:27AM  
May-13-21 08:00AM  
May-11-21 04:29PM  
May-06-21 09:41PM  
Apr-15-21 10:54AM  
Apr-14-21 09:15AM  
Apr-12-21 08:00AM  
06:00AM  
Apr-09-21 06:16AM  
Mar-30-21 08:00AM  
Mar-25-21 04:05PM  
03:15PM  
Mar-22-21 04:05PM  
Mar-18-21 08:00AM  
Mar-11-21 07:55AM  
Mar-08-21 08:00AM  
Mar-01-21 08:00AM  
Feb-16-21 08:00AM  
Feb-02-21 08:00AM  
Jan-29-21 08:00AM  
Jan-06-21 08:00AM  
Dec-28-20 11:26AM  
Dec-17-20 12:23PM  
Dec-15-20 05:18PM  
Dec-11-20 05:39PM  
05:25PM  
05:23PM  
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Huntsman Ronald KirkChief Executive OfficerSep 21Buy4.315,00021,55015,500Sep 22 03:09 PM
Huntsman Ronald KirkChief Executive OfficerAug 17Buy3.005,00015,00010,500Aug 18 03:47 PM